IPHA
Innate Pharma
IPHA
IPHA
8 hedge funds and large institutions have $545K invested in Innate Pharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$19.3K |
Top Sellers
| 1 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
$177K |
| 2 |
Citadel Advisors
Miami,
Florida
|
$48.7K |
| 3 |
Optiver Holding
Amsterdam,
Netherlands
|
$199K |
| 4 |
Barclays
London,
United Kingdom
|
$1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Optiver Holding
Amsterdam,
Netherlands
| $199K | -$1.29K | -564 | -0.6% |
|
|
ETC
2
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| $177K | -$20.4K | -8,887 | -10% |
|
3
Morgan Stanley
New York
| $99.7K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $48.7K | -$5.18K | -2,260 | -10% |
|
|
5
UBS Group
Zurich,
Switzerland
| $19.3K | +$18.6K | +8,111 | +2,731% |
|
|
6
Barclays
London,
United Kingdom
| $1K | -$342 | -105 | -25% |
|
7
RhumbLine Advisers
Boston,
Massachusetts
| $469 | – | – | – |
|
|
SPIA
8
Steward Partners Investment Advisory
New York
| $458 | – | – | – |
|